[ad_1] A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after…
Tag: CRISPR Therapeutics AG
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
[ad_1] Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test. Md Babul Hosen | Istock | Getty Images The U.S. Food and…
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
[ad_1] At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more than a…
CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting
[ad_1] ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral…
These innovation stocks owned by Cathie Wood have double-digit upside, according to analysts
[ad_1] Cathie Wood just scored her best month ever as her innovation stocks staged a big comeback, and some of her darlings still have double-digit upside ahead, according to Wall…
Cramer’s lightning round: CRISPR Therapeutics will work perfectly in this market
[ad_1] Clearfield Inc: “There’s an analyst that cut numbers and the stock fell apart. That was ridiculous.” Jim Cramer’s Guide to Investing Click here to download Jim Cramer’s Guide to Investing at…